| Autor: |
Lluis, Asmarats, Jean-Bernard, Masson, Paolo A, Pagnotta, Stéphane, Cook, Mike, Foresti, Réda, Ibrahim, Adam, Sukiennik, Robert, Sabiniewicz, Diego, Maffeo, Julio, Carballo, Ignacio, Cruz-González, Carmelo, Grasso, Francesco, Pisano, Gaetano, Senatore, Giuseppe, Tarantini, Adolphe, Kasongo, Mauro, Chiarito, Serban, Puricel, Nathan, Messas, Jose Carlos, Moreno-Samos, Gilles, O'Hara, Josep, Rodés-Cabau |
| Jazyk: |
angličtina |
| Rok vydání: |
2018 |
| Předmět: |
|
| Popis: |
This study sought to evaluate the feasibility, safety, and efficacy of the Ultraseal device for left atrial appendage closure (LAAC) (Cardia, Eagan, Minnesota) in patients with nonvalvular atrial fibrillation at high bleeding risk.The Ultraseal device is a novel bulb-and-sail designed LAAC device, with an articulating joint enabling conformability to heterogeneous angles and shapes of appendage anatomy.This was a multicenter study including consecutive patients undergoing LAAC with the Ultraseal device at 15 Canadian and European sites. Periprocedural and follow-up events were systematically collected, and transesophageal echocardiography at 45 to 180 days post-procedure was routinely performed in all centers but 3.A total of 126 patients (mean age 75 ± 8 years; mean CHAIn this initial multicenter experience, LAAC with the Ultraseal device was associated with a high implant success rate and a very low incidence of periprocedural complications. There were no late device-related clinical events and promising efficacy results were observed regarding thromboembolic prevention at midterm follow-up. Larger studies are further warranted to confirm the long-term safety and efficacy of this novel device. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
